GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Gross Margin %

Endo (NDOI) Gross Margin % : -5.12% (As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Endo Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Endo's Gross Profit for the three months ended in Sep. 2024 was $-22 Mil. Endo's Revenue for the three months ended in Sep. 2024 was $427 Mil. Therefore, Endo's Gross Margin % for the quarter that ended in Sep. 2024 was -5.12%.


The historical rank and industry rank for Endo's Gross Margin % or its related term are showing as below:

NDOI' s Gross Margin % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 29.81
Current: 29.81


During the past 0 years, the highest Gross Margin % of Endo was 29.81%. The lowest was 0.00%. And the median was 0.00%.

NDOI's Gross Margin % is ranked worse than
78.84% of 969 companies
in the Drug Manufacturers industry
Industry Median: 47.02 vs NDOI: 29.81

Endo had a gross margin of -5.12% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Endo was 0.00% per year.


Endo Gross Margin % Historical Data

The historical data trend for Endo's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Gross Margin % Chart

Endo Annual Data
Trend
Gross Margin %

Endo Quarterly Data
Jun23 Sep23 Apr24 Sep24
Gross Margin % 57.24 49.01 55.40 -5.12

Competitive Comparison of Endo's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Endo's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Endo's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Endo's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Endo's Gross Margin % falls into.



Endo Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Endo's Gross Margin for the fiscal year that ended in . 20 is calculated as

Gross Margin % (A: . 20 )=Gross Profit (A: . 20 ) / Revenue (A: . 20 )
=0 /
=(Revenue - Cost of Goods Sold) / Revenue
=( - ) /
=N/A %

Endo's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=-21.8 / 426.506
=(Revenue - Cost of Goods Sold) / Revenue
=(426.506 - 448.324) / 426.506
=-5.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Endo  (OTCPK:NDOI) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Endo had a gross margin of -5.12% for the quarter that ended in Sep. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Endo Gross Margin % Related Terms

Thank you for viewing the detailed overview of Endo's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Endo Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1400 Atwater Drive, Malvern, PA, USA, 19355
Endo Inc is a diversified specialty pharmaceutical company that develops, manufactures, markets and sells a broad portfolio of pharmaceutical products across four reportable segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.